WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.20), $0.13 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $22.1 million versus the consensus estimate of $7.94 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.